KM-023（Kamari Pharma）

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameKM-023（Kamari Pharma）
Drug Alias NameKM-023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 3 channel antagonists
TargetsTransient receptor potential cation channel subfamily V member 3
Therapy Area/IndicationsSkin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKamari Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKamari Pharma Ltd
Inactive CompaniesN/A
Active IndicationsSkin Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A